MicroRNA-145 is Involved in Endothelial Cell Dysfunction and Acts As a Promising Biomarker of Acute Coronary Syndrome

Overview

Journal Eur J Med Res

Publisher Biomed Central

Specialty General Medicine

Date 2020 Mar 18

PMID 32178736

Citations 14

Authors

Shanshan Wu

Huijuan Sun

Bin Sun

Affiliations

Soon will be listed here.

Abstract

Background: Acute coronary syndrome (ACS) is a serious type of cardiovascular diseases. This study aimed to investigate the expression patterns and clinical value of microRNA-145 (miR-145) in ACS patients, and further uncover the function of miR-145 in ACS rats.

Methods: Quantitative real-time PCR was used to estimate the expression of miR-145. Diagnostic value of miR-145 was evaluated, and its correlation with endothelial injury marker (vWF and H-FABP) and pro-inflammatory cytokines (IL-6 and TNF-α) was analyzed. Coronary artery ligation was adopted to construct the ACS rat model, and the effects of miR-145 on endothelial injury, inflammation and vascular endothelial cells (VECs) biological function were examined.

Results: Downregulated expression of miR-145 was found in the ACS serum samples compared with the healthy controls. The expression of miR-145 was proved to be a diagnostic biomarker and negatively correlated with vWF, H-FABP, IL-6 and TNF-α. The similar serum expression trends of miR-145 in ACS patients were also observed in the ACS rats, and the overexpression of miR-145 could decrease the elevated vWF, H-FABP, IL-6 and TNF-α in the animal model. Moreover, the upregulation of miR-145 in VECs led to promoted proliferation and migration. The bioinformatics prediction data and luciferase report results indicated that FOXO1 was a direct target of miR-145.

Conclusions: In conclusion, it was hypothesized that serum decreased expression of miR-145 may serve as a potential diagnostic biomarker in ACS patients. Overexpression of miR-145 may improve the endothelial injury and abnormal inflammation through targeting FOXO1, indicating that miR-145 serves as a candidate therapeutic target of ACS.

Citing Articles

MiRNA-34a, miRNA-145, and miRNA-222 Expression, Matrix Metalloproteinases, TNF-α and VEGF in Patients with Different Phenotypes of Coronary Artery Disease.

Iusupova A, Pakhtusov N, Slepova O, Khabarova N, Privalova E, Bure I Int J Mol Sci. 2024; 25(23.

PMID: 39684689 PMC: 11641108. DOI: 10.3390/ijms252312978.

Endothelial dysfunction: molecular mechanisms and clinical implications.

Wang X, He B MedComm (2020). 2024; 5(8):e651.

PMID: 39040847 PMC: 11261813. DOI: 10.1002/mco2.651.

Circulating miRNA-21 as a diagnostic biomarker for acute coronary syndrome: a systematic review and meta-analysis of diagnostic test accuracy study.

He J, Li S, Wu X, Chen X, Yan D, Wang X Cardiovasc Diagn Ther. 2024; 14(3):328-339.

PMID: 38975002 PMC: 11223935. DOI: 10.21037/cdt-23-385.

Hypoxia-induced circRNAs encoded by PPARA are highly expressed in human cardiomyocytes and are potential clinical biomarkers of acute myocardial infarction.

Huang S, Wu Z, Zhou Y Eur J Med Res. 2024; 29(1):159.

PMID: 38475969 PMC: 10929223. DOI: 10.1186/s40001-024-01753-3.

Genetic Variants Identified by Whole Exome Sequencing in a Large Italian Family with High Plasma Levels of Factor VIII and Von Willebrand Factor.

Spena S, Cairo A, Gianniello F, Pappalardo E, Mortarino M, Garagiola I Int J Mol Sci. 2023; 24(18).

PMID: 37762470 PMC: 10532311. DOI: 10.3390/ijms241814167.

References

Li Z, He Q, Zhai X, You Y, Li L, Hou Y . Foxo1-mediated inflammatory response after cerebral hemorrhage in rats. Neurosci Lett. 2016; 629:131-136. DOI: 10.1016/j.neulet.2016.06.013. View

Libby P, Theroux P . Pathophysiology of coronary artery disease. Circulation. 2005; 111(25):3481-8. DOI: 10.1161/CIRCULATIONAHA.105.537878. View

Zhang Y, Wen X, Hu X, Cheng L, Yu J, Wei Z . Downregulation of miR-145-5p correlates with poor prognosis in gastric cancer. Eur Rev Med Pharmacol Sci. 2016; 20(14):3026-30. View

Ren J, Ma R, Zhang Z, Li Y, Lei P, Men J . Effects of microRNA-330 on vulnerable atherosclerotic plaques formation and vascular endothelial cell proliferation through the WNT signaling pathway in acute coronary syndrome. J Cell Biochem. 2017; 119(6):4514-4527. DOI: 10.1002/jcb.26584. View

Gong L, Chang H, Zhang J, Guo G, Shi J, Xu H . Astragaloside IV Protects Rat Cardiomyocytes from Hypoxia-Induced Injury by Down-Regulation of miR-23a and miR-92a. Cell Physiol Biochem. 2018; 49(6):2240-2253. DOI: 10.1159/000493827. View

Hao W, Liu H, Zhou L, Sun Y, Su H, Ni J . MiR-145 regulates osteogenic differentiation of human adipose-derived mesenchymal stem cells through targeting FoxO1. Exp Biol Med (Maywood). 2017; 243(4):386-393. PMC: 6022928. DOI: 10.1177/1535370217746611. View

Luo X, Zhu X, Li Y, Wang X, Yin W, Ge Y . MicroRNA-150 restores endothelial cell function and attenuates vascular remodeling by targeting PTX3 through the NF-κB signaling pathway in mice with acute coronary syndrome. Cell Biol Int. 2018; 42(9):1170-1181. DOI: 10.1002/cbin.10985. View

Wang E, Jia X, Ruan C, Ge Z . miR-487b mitigates chronic heart failure through inhibition of the IL-33/ST2 signaling pathway. Oncotarget. 2017; 8(31):51688-51702. PMC: 5584280. DOI: 10.18632/oncotarget.18393. View

Negoita S, Sandesc D, Rogobete A, Dutu M, Bedreag O, Papurica M . miRNAs Expressions and Interaction with Biological Systems in Patients with Alzheimer`s Disease. Using miRNAs as a Diagnosis and Prognosis Biomarker. Clin Lab. 2017; 63(9):1315-1321. DOI: 10.7754/Clin.Lab.2017.170327. View

10.

He X, Ji J, Wang T, Wang M, Chen X . Upregulation of Circulating miR-195-3p in Heart Failure. Cardiology. 2017; 138(2):107-114. DOI: 10.1159/000476029. View

11.

Darabi F, Aghaei M, Movahedian A, Elahifar A, Pourmoghadas A, Sarrafzadegan N . Association of serum microRNA-21 levels with Visfatin, inflammation, and acute coronary syndromes. Heart Vessels. 2016; 32(5):549-557. DOI: 10.1007/s00380-016-0913-z. View

12.

Huang J, Yang Q, He L, Huang J . Role of TLR4 and miR-155 in peripheral blood mononuclear cell-mediated inflammatory reaction in coronary slow flow and coronary arteriosclerosis patients. J Clin Lab Anal. 2017; 32(2). PMC: 6817041. DOI: 10.1002/jcla.22232. View

13.

Makki N, Brennan T, Girotra S . Acute coronary syndrome. J Intensive Care Med. 2013; 30(4):186-200. DOI: 10.1177/0885066613503294. View

14.

Dong C, Wang Z, Chen S . Neutrophil to lymphocyte ratio predict mortality and major adverse cardiac events in acute coronary syndrome: A systematic review and meta-analysis. Clin Biochem. 2017; 52:131-136. DOI: 10.1016/j.clinbiochem.2017.11.008. View

15.

Cui C, Ye X, Chopp M, Venkat P, Zacharek A, Yan T . miR-145 Regulates Diabetes-Bone Marrow Stromal Cell-Induced Neurorestorative Effects in Diabetes Stroke Rats. Stem Cells Transl Med. 2016; 5(12):1656-1667. PMC: 5189645. DOI: 10.5966/sctm.2015-0349. View

16.

Yang F, Liu W, Yan X, Zhou H, Zhang H, Liu J . Effects of mir-21 on Cardiac Microvascular Endothelial Cells After Acute Myocardial Infarction in Rats: Role of Phosphatase and Tensin Homolog (PTEN)/Vascular Endothelial Growth Factor (VEGF) Signal Pathway. Med Sci Monit. 2016; 22:3562-3575. PMC: 5056537. DOI: 10.12659/msm.897773. View

17.

Wei H, Wen-Ming C, Jun-Bo J . Plasma miR-145 as a novel biomarker for the diagnosis and radiosensitivity prediction of human cervical cancer. J Int Med Res. 2017; 45(3):1054-1060. PMC: 5536414. DOI: 10.1177/0300060517709614. View

18.

Li R, Shen Q, Wu N, He M, Liu N, Huang J . MiR-145 improves macrophage-mediated inflammation through targeting Arf6. Endocrine. 2018; 60(1):73-82. DOI: 10.1007/s12020-018-1521-8. View

19.

Zhong J, Ren X, Chen Z, Zhang H, Zhou L, Yuan J . miR-21-5p promotes lung adenocarcinoma progression partially through targeting SET/TAF-Iα. Life Sci. 2019; 231:116539. DOI: 10.1016/j.lfs.2019.06.014. View

20.

Sunaga H, Koitabashi N, Iso T, Matsui H, Obokata M, Kawakami R . Activation of cardiac AMPK-FGF21 feed-forward loop in acute myocardial infarction: Role of adrenergic overdrive and lipolysis byproducts. Sci Rep. 2019; 9(1):11841. PMC: 6694166. DOI: 10.1038/s41598-019-48356-1. View